Rizvi, Syed
https://orcid.org/0009-0000-0081-0239
Mayo Clinic
The University of Texas Southwestern Medical Center
Citations 1
ENGINE: A Phase III Randomized Placebo Controlled Study of Enzastaurin/R-CHOP as Frontline Therapy in High-Risk Diffuse Large B-Cell Lymphoma Patients with the Genomic Biomarker DGM1
Nowakowski, Grzegorz S. , Zhu, Jun , Zhang, Qingyuan , Sun, Xiuhua , Maly, Joseph, Rizvi, Syed , Song, Yongping , Jing, Hongmei , Cao, Junning , Zhang, Lei , Han, Isabel, Sun, Joan, Jivani, Manoj A., Liu, Young, Heineman, Thomas C. , Smith, Stephen D. , Brody, Joshua , Song, Yuqin , Lansigan, Frederick , Lue, Jennifer Kimberly , Luo, Wen , Li, Ling
Future Oncology | April 6, 2020 | Volume: 16 | Issue: 15 | Pages: 991-999
